A Phase I Study of Niclosamide in Combination With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2017
At a glance
- Drugs Enzalutamide (Primary) ; Niclosamide (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 11 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated
- 08 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.